Clin2
NCT07198347Possibly a fitNot yet recruiting

New medicine for acute bronchitis with cough and phlegm

Acute Bronchitis

Part of Infections, Lungs & breathing clinical trials.

This study tests a new medicine, AG2001, to see if it safely helps adults with acute bronchitis (a sudden chest cold with cough and phlegm). If you have a recent, bothersome cough and sputum, this trial might offer a new treatment option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
300 people
Ages
19 years to 64 years
Study type
Interventional

Who can take part

  • You must be between 19 and 64 years old.
  • Your cough and phlegm started within the last 2 weeks and are at least moderately bothersome.
  • You should not have a high fever (under 101.3°F or 38.5°C).
  • You must not have chronic lung problems like COPD, asthma, or pneumonia.
  • You must be willing to give written consent to join the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06411925Recruiting· Phase 4
Atock Dry Syrup for children with acute bronchitis

This trial tests a new cough syrup (Atock Dry Syrup) for children with acute bronchitis. If your child has a bad cough, wheezing, and symptoms started in the last 2 days, this treatment may help ease their symptoms.

Seoul
NCT07201051Recruiting· Phase 2
Testing a new drug for people with bronchiectasis

This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.

Mobile, Alabama
NCT07731919Not yet recruiting· Phase 2
Inhaled study drug for adults with bronchiectasis

This trial tests an inhaled medication for adults with bronchiectasis, a lung condition that causes chronic cough and mucus. The goal is to see if the drug is safe and helpful in reducing symptoms and infections.

NCT07650084Recruiting· Phase 3
Testing BLU-5937 for hard-to-treat chronic cough

This 24-week study tests whether a new medicine called BLU-5937 can help adults whose chronic cough hasn't improved with standard treatments. Chronic cough that lasts a year or longer can seriously affect quality of life, and this trial explores whether this drug might provide relief.

Leshan, Sichuan
NCT07873632Not yet recruiting· Phase 4
Guaifenesin for mucus in chronic bronchitis

This study tests whether the over-the-counter medicine guaifenesin (also known as Mucinex) can make mucus easier to cough up in people with chronic bronchitis. It aims to see if this treatment helps clear mucus and improve breathing.

Chapel Hill, North Carolina
NCT07330856Recruiting· Phase 4
Testing treatments for recent dry or productive cough

This trial tests treatments for a recent dry or productive cough caused by a common viral infection like a cold or sore throat. It aims to find options that are safe and effective for adults who are otherwise healthy.

Clermont-Ferrand

Hear when a new Acute Bronchitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.